Cargando…
Stereotactic or Conventional Radiation for Early-Stage Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Stereotactic ablative radiotherapy (SABR) has been increasingly used for the treatment of inoperable early-stage non-small cell lung cancer (NSCLC). It has been shown to provide promising local control (LC) and toxicity in prospective trials. However, randomized trials have shown conflicting results...
Autores principales: | Mutsaers, Adam, Zhang, Tina Wanting, Louie, Alexander, Rodrigues, George, Palma, David, Qu, Melody |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224746/ https://www.ncbi.nlm.nih.gov/pubmed/37252503 http://dx.doi.org/10.7759/cureus.38198 |
Ejemplares similares
-
Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020) -
Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting
por: Chaurasia, Avinash R, et al.
Publicado: (2021) -
Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution
por: Doupnik, Nathan P, et al.
Publicado: (2022) -
Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma
por: Jumeau, Raphaël, et al.
Publicado: (2016) -
Clinical Outcomes After Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer: A Single Institutional Study
por: Abdalmassih, Michael, et al.
Publicado: (2020)